ImmuCell Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-5.77	-2.49	-0.08	-1.02	-1.3	-2.32	-0.17	0.51	1.21	-0.17	Upgrade
Depreciation & Amortization	2.72	2.49	2.46	2.35	2.27	1.52	0.9	0.8	0.53	0.45	Upgrade
Share-Based Compensation	0.37	0.27	0.14	0.25	0.31	0.34	0.2	0.07	0.02	0.03	Upgrade
Other Operating Activities	-1.99	-1.8	-1.57	-0.26	-1.05	0.08	0.24	-1.6	1.14	-0.01	Upgrade
Operating Cash Flow	-4.67	-1.54	0.95	1.32	0.23	-0.37	1.18	-0.22	2.9	0.3	Upgrade
Operating Cash Flow Growth	-	-	-27.47%	463.39%	-	-	-	-	859.19%	-72.48%	Upgrade
Capital Expenditures	-1.89	-3.96	-2.59	-4.03	-0.94	-1.78	-17.71	-3.56	-2.65	-1.54	Upgrade
Acquisitions	0	0	0	0	-0.01	-0.01	-0.01	-0.47	0	0	Upgrade
Change in Investments	0	0	1	1.46	-2.45	0	5.45	-0.5	-1.97	0	Upgrade
Investing Cash Flow	-1.89	-3.96	-1.6	-2.57	-3.4	-1.79	-12.27	-4.52	-4.62	-1.54	Upgrade
Share Issuance / Repurchase	0.02	0.03	4.24	0	8.3	0.1	3.82	8.51	0.12	0	Upgrade
Debt Issued / Paid	1.73	1.08	-0.37	1.91	-1.36	0.79	5.93	-0.18	2.3	-0.19	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	0.03	-	Upgrade
Financing Cash Flow	1.75	1.11	3.88	1.91	6.94	0.89	9.75	8.32	2.44	-0.19	Upgrade
Net Cash Flow	-4.81	-4.39	3.24	0.66	3.77	-1.28	-1.35	3.58	0.72	-1.42	Upgrade
Free Cash Flow	-6.56	-5.51	-1.64	-2.71	-0.71	-2.15	-16.54	-3.78	0.25	-1.23	Upgrade
Free Cash Flow Margin	-37.57%	-29.66%	-8.52%	-17.67%	-5.16%	-19.60%	-158.56%	-39.58%	2.42%	-16.23%	Upgrade
Free Cash Flow Per Share	-0.85	-0.71	-0.22	-0.38	-0.10	-0.39	-3.34	-0.89	0.08	-0.41	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).